Literature DB >> 1357245

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn.

J D Roberts1, D M Polaner, P Lang, W M Zapol.   

Abstract

Nitric oxide (NO) has vasodilatory effects on the pulmonary vasculature in adults and animals. We examined the effects on systemic oxygenation and blood pressure of inhaling up to 80 parts per million by volume of NO at FiO2 0.9 for up to 30 minutes by 6 infants with persistent pulmonary hypertension of the newborn (PPHN). In all infants this treatment rapidly and significantly increased preductal oxygen saturation (SpO2); in 5 infants postductal SpO2 and oxygen tensions also increased. Inhalation of NO did not cause systemic hypotension or raise methaemoglobin. These data suggest that low levels of inhaled NO have an important role in the reversal of hypoxaemia due to PPHN.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357245     DOI: 10.1016/0140-6736(92)92686-a

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  105 in total

Review 1.  Response to inhaled nitric oxide in premature and term neonates.

Authors:  T Hoehn; M F Krause
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure.

Authors:  R L Smyth
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

3.  Improving survival in trauma patients with acute respiratory distress syndrome.

Authors:  U Kaisers; T Busch
Journal:  Intensive Care Med       Date:  2001-07       Impact factor: 17.440

4.  Cerebral blood flow during treatment for pulmonary hypertension.

Authors:  S Kusuda; N Shishida; N Miyagi; M Hirabayashi; T J Kim
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

5.  Endothelial nitric oxide synthase in hypoxic newborn porcine pulmonary vessels.

Authors:  A A Hislop; D R Springall; H Oliveira; J S Pollock; J M Polak; S G Haworth
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

6.  Inhaled nitric oxide delivery and monitoring.

Authors:  F J Montgomery; A D Berssenbrugge
Journal:  J Clin Monit Comput       Date:  1999-07       Impact factor: 2.502

7.  Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome.

Authors:  H Gerlach; D Pappert; K Lewandowski; R Rossaint; K J Falke
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

8.  Alternatives to ECMO.

Authors:  S M Donn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-03       Impact factor: 5.747

9.  Conversion of inhaled nitric oxide to nitrate in man.

Authors:  U N Westfelt; G Benthin; S Lundin; O Stenqvist; A Wennmalm
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide.

Authors:  J D Young; O Dyar; L Xiong; S Howell
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.